LUXEMBOURG--(BUSINESS WIRE)-- Regulatory News: Eurofins (Paris:ERF) U.S. Clinical Diagnostics announced the launch date of its pooled PCR test to detect SARS-CoV-2 and significantly reduce the price ...
“We are thrilled to begin testing anywhere in the United States and worldwide with our first-of-their-kind mobile labs,” said Eric Canonico, CEO of MOTOPARA Foundation. “With the recent surge of COVID ...
Karyotype analysis includes complete chromosome analysis of at least twenty metaphases with at least two cut karyotypes. The presence or absence of an acquired clonal chromosomal abnormality may aid ...
Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, today announced the launch of its first ultrasensitive multiplexed digital PCR assay, the ddPLEX ...
Reliable and readily available diagnostic testing capacities are absolutely critical for countries battling the pandemic. For now, most COVID diagnostics rely on routine assays that use the polymerase ...
When it comes to detecting rare cancer-causing mutations, both sensitivity and specificity matter. In the past few years, digital PCR (dPCR) has captured the attention of researchers and clinicians ...
CE-marked under the EU IVDR regulation, Diagnostics.AI's platform is the first to deliver AI algorithmic transparency and per-test auditability for clinical PCR diagnostics As the May 26th CE-IVDR ...
Modifications and adaptations continue to improve how we use PCR, spurring a new level of creativity in genomics hypotheses and enabling a broad versatility in applications. PCR has the speed, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback